Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
If we’re being totally honest, while it had its moments, last week’s Jamie Dimon Congressional hearing to discuss Whale Boy was a bit of a letdown, theatrically-speaking. This was probably due in large part to the fact that it was conducted by the Senate Banking Committee, and the Senate typically comes off intelligent and reasonable compared to the House,* and proceeded accordingly. As we surely don’t have to tell you, this is not the kind of hearing we are interested in.
We are interested in hearings that involve Congressmen and women screaming “I CAN’T BELIEVE YOU HAVEN’T BEEN PROSECUTED YET!!!” at financial services employees and accusing them of dressing up as Girl Scouts in order to deceive the public. We are interested in hearings that involve the use of the term “smart-alecks.” We are interested in hearings that involve subjects being told to be more like Magic Johnson. We are interested in hearings that involve subjects who’ve never worked for Goldman Sachs being grilled until they break about working at Goldman Sachs. We are interested in hearings that involve bath salts, or the suggestion that the people conducting it have taken a bunch of them and at any moment might leap across the dais to eat the witness’s face off. Fortunately, we might get the chance for all that and more tomorrow, when Dimon makes another trip down to D.C. to appear before the House Financial Services Committee to talk whales. Don’t fail us.
In House Testimony, Dimon Sticks To Script [Dealbook]
*Make no mistake, most of them fell short of becoming Rhodes Scholar Quarterfinalists